154 related articles for article (PubMed ID: 30280791)
21. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
22. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins.
Musset L; Duarte F; Gaillard O; Du LT; Bilala J; Galli J; Preud'homme JL
Clin Immunol Immunopathol; 1994 Feb; 70(2):166-70. PubMed ID: 8299232
[TBL] [Abstract][Full Text] [Related]
23. A role for hepatitis C virus infection in type II cryoglobulinemia.
Agnello V; Chung RT; Kaplan LM
N Engl J Med; 1992 Nov; 327(21):1490-5. PubMed ID: 1383822
[TBL] [Abstract][Full Text] [Related]
24. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
25. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
[TBL] [Abstract][Full Text] [Related]
26. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
Schott P; Hartmann H; Ramadori G
Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
[TBL] [Abstract][Full Text] [Related]
28. Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II.
Szymanski IO; Pullman JM; Underwood JM
Am J Clin Pathol; 1994 Sep; 102(3):278-83. PubMed ID: 7521986
[TBL] [Abstract][Full Text] [Related]
29. [Mixed cryoglobulinemia in hepatitis C virus infection].
Musset L; Lunel F; Cacoub P; Opolon P
Presse Med; 1996 Apr; 25(12):595-8. PubMed ID: 8657676
[TBL] [Abstract][Full Text] [Related]
30. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
De Re V; De Vita S; Sansonno D; Gasparotto D; Simula MP; Tucci FA; Marzotto A; Fabris M; Gloghini A; Carbone A; Dammacco F; Boiocchi M
Rheumatology (Oxford); 2006 Jun; 45(6):685-93. PubMed ID: 16399842
[TBL] [Abstract][Full Text] [Related]
31. Cryoglobulins Today: Detection and Immunologic Characteristics of 1,675 Positive Samples From 13,439 Patients Obtained Over Six Years.
Kolopp-Sarda MN; Nombel A; Miossec P
Arthritis Rheumatol; 2019 Nov; 71(11):1904-1912. PubMed ID: 31136095
[TBL] [Abstract][Full Text] [Related]
32. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis.
Fornasieri A; D'Amico G
Nephrol Dial Transplant; 1996; 11 Suppl 4():25-30. PubMed ID: 8918748
[TBL] [Abstract][Full Text] [Related]
33. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies.
Bonagura VR; Artandi SE; Agostino N; Tao MH; Morrison SL
DNA Cell Biol; 1992 Apr; 11(3):245-52. PubMed ID: 1567557
[TBL] [Abstract][Full Text] [Related]
34. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
[TBL] [Abstract][Full Text] [Related]
36. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia.
Pietrogrande M; Corona M; Milani S; Rosti A; Ramella M; Tordato G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S109-13. PubMed ID: 8730489
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
[TBL] [Abstract][Full Text] [Related]
38. Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics.
Kolopp-Sarda MN; Miossec P
Front Immunol; 2020; 11():1183. PubMed ID: 32695098
[TBL] [Abstract][Full Text] [Related]
39. [Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and a case report].
Filippini D; Colombo F; Jann S; Cornero R; Canesi B
Reumatismo; 2002; 54(2):150-5. PubMed ID: 12105684
[TBL] [Abstract][Full Text] [Related]
40. Importance of the IgG isotype, not the state of glycosylation, in determining human rheumatoid factor binding.
Newkirk MM; Lemmo A; Rauch J
Arthritis Rheum; 1990 Jun; 33(6):800-9. PubMed ID: 2363735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
